Maktaba

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Prostate‐specific antigen screening impacts on biochemical recurrence in patients with clinically localized prostate cancer.

Authors : Hashimoto, Takeshi¹; Ohori, Makoto¹; Shimodaira, Kenji¹

Source: International Journal of Urology. Jun2018, Vol. 25 Issue 6, p561-567. 7p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Utility of early transperineal template-guided prostate biopsy for risk stratification in men undergoing active surveillance for prostate cancer.

Authors : Voss, James¹; Pal, Raj¹; Ahmed, Shaista¹

Source: BJU International. Jun2018, Vol. 121 Issue 6, p863-870. 8p.

Record details

Read Online Read More Add to Saved list

Academic Journal

What is the Prostate-Specific Antigen Cut-Off Value to Detect Clinically Significant Prostate Cancer According to Age in Turkey?

Authors : Ebiloğlu, Turgay¹; Kaya, Engin¹

Source: Üroonkoloji Bülteni. Jun2018, Vol. 17 Issue 2, p49-53. 5p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Baseline prostate-specific antigen levels following treatment with abiraterone acetate as a prognostic factor in castration-resistant prostate cancer.

Authors : Hiroshige, Tasuku¹ ; Eguchi, Yoshiro¹; Yoshizumi, Osamu¹

Source: Oncology Letters. May2018, Vol. 15 Issue 5, p6806-6814. 9p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Transurethral balloon dilatation of the Prostate and Transurethral Plasmakinetic resection of the Prostate in the treatment of Prostatic Hyperplasia.

Authors : Yanhua Chang¹ ; Jingyi Chang²; Hui Wang¹

Source: Pakistan Journal of Medical Sciences. May/Jun2018, Vol. 34 Issue 3, p1-4. 4p.

Record details

Read Online Read More Add to Saved list

Academic Journal

CAVEATS OF PROSTATE CANCER DIAGNOSIS: DIAGNOSTIC UTILITY STUDY OF DIGITAL RECTAL EXAMINATION, PROSTATE VOLUME AND PROSTATE SPECIFIC ANTIGEN.

Authors : Rehman, Ashfaq Ur¹; Khattak, Ikram Ullah¹ ; Jan, Mir Alam¹

Source: JPMI: Journal of Postgraduate Medical Institute. 2018, Vol. 32 Issue 2, p211-215. 5p.

Record details

Read Online Read More Add to Saved list

Academic Journal

The utility and limitations of contrast-enhanced transrectal ultrasound scanning for the detection of prostate cancer in different area of prostate.

Authors : Xie, Shao Wei¹; Dong, Bai Jun²; Xia, Jian Guo¹

Source: Clinical Hemorheology & Microcirculation. 2018, Vol. 70 Issue 3, p281-290. 10p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Lymphocyte-to-monocyte ratio is a valuable marker to predict prostate cancer in patients with prostate specific antigen between 4 and 10 ng/dl.

Authors : Caglayan, Volkan¹ ; Onen, Efe¹ ; Avci, Sinan¹

Source: Archives of Italian Urology & Andrology / Archivio Italiano di Urologia Andrologia. 2018, Vol. 90 Issue 4, p270-275. 6p.

Record details

Read Online Read More Add to Saved list

Academic Journal

The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy.

Authors : Murray, Nigel P.^1,2 ; Aedo, Socrates²; Fuentealba, Cynthia¹

Source: Ecancermedicalscience. 2018, Vol. 12 Issue 844-874, p1-11. 11p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Prostate Biopsy Characteristics: A Comparison Between the Pre- and Post-2012 United States Preventive Services Task Force (USPSTF) Prostate Cancer Screening Guidelines.

Authors : Shah, Navin¹; Ioffe, Vladimir²; Huebner, Thomas³

Source: Reviews in Urology. 2018, Vol. 20 Issue 2, p77-83. 7p.

Record details

Read Online Read More Add to Saved list

Search Results

Your Filters

Prostate‐specific antigen screening impacts on biochemical recurrence in patients with clinically localized prostate cancer.

Utility of early transperineal template-guided prostate biopsy for risk stratification in men undergoing active surveillance for prostate cancer.

What is the Prostate-Specific Antigen Cut-Off Value to Detect Clinically Significant Prostate Cancer According to Age in Turkey?

Baseline prostate-specific antigen levels following treatment with abiraterone acetate as a prognostic factor in castration-resistant prostate cancer.

Transurethral balloon dilatation of the Prostate and Transurethral Plasmakinetic resection of the Prostate in the treatment of Prostatic Hyperplasia.

CAVEATS OF PROSTATE CANCER DIAGNOSIS: DIAGNOSTIC UTILITY STUDY OF DIGITAL RECTAL EXAMINATION, PROSTATE VOLUME AND PROSTATE SPECIFIC ANTIGEN.

The utility and limitations of contrast-enhanced transrectal ultrasound scanning for the detection of prostate cancer in different area of prostate.

Lymphocyte-to-monocyte ratio is a valuable marker to predict prostate cancer in patients with prostate specific antigen between 4 and 10 ng/dl.

The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy.

Prostate Biopsy Characteristics: A Comparison Between the Pre- and Post-2012 United States Preventive Services Task Force (USPSTF) Prostate Cancer Screening Guidelines.

Contact

Follow us